United Therapeutics
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has United Therapeutics's balance sheet done over the years? Its assets were worth $7,167,000,000 last year, which is more than in the previous period. 16% of United Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $1,182,200,000, which means an decrease by -5% compared compared to last year.
Debt to Assets
| 2014 | 1884410000 | 618.83M | 32.84% |
|---|---|---|---|
| 2015 | 2184445000 | 584.79M | 26.77% |
| 2016 | 2325600000 | 463.4M | 19.93% |
| 2017 | 2879400000 | 777.6M | 27.01% |
| 2018 | 3401000000 | 612.4M | 18.01% |
| 2019 | 3913400000 | 1.13B | 28.95% |
| 2020 | 4615000000 | 1.21B | 26.43% |
| 2021 | 5169100000 | 1.21B | 23.41% |
| 2022 | 6044500000 | 1.24B | 20.64% |
| 2023 | 7167000000 | 1.18B | 16.5% |
UTHR Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 1.20B | 961.2M | 894.8M | 738.7M | 738.4M | 669.2M | 705.1M | 1.02B | 831.79M | 397.69M |
Short term investments | 1.78B | 1.87B | 1.03B | 1.09B | 747.5M | 746.7M | 222.3M | 27.8M | 121.97M | 297.84M |
Net receivables | 278.9M | 220.4M | 198.7M | 157.4M | 151.4M | 175.7M | 297.1M | 214.5M | 192.82M | 162.28M |
Inventory | 111.8M | 102M | 93.8M | 86.5M | 93.4M | 101M | 107.9M | 100M | 81.33M | 66.92M |
Other current assets | 166.2M | 219.2M | 100.4M | 88.3M | 133.8M | 75.4M | 115.5M | 59.5M | 169.37M | 49.44M |
Total current assets | 3.55B | 3.38B | 2.32B | 2.16B | 1.86B | 1.76B | 1.44B | 1.42B | 1.27B | 974.19M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 1.04B | 861.5M | 780.9M | 731.6M | 738.5M | 699.7M | 545.7M | 489.3M | 495.77M | 478.42M |
Goodwill | 33.7M | 28M | 28M | 28M | 28M | 31.5M | 13.7M | 10.3M | 10.26M | 10.26M |
Intangible assets | 80.5M | 16.5M | 16.6M | 130.1M | 130.3M | 139.3M | 31.9M | 23.5M | 18.11M | 19.20M |
Long term investments | 1.90B | 1.31B | 1.64B | 1.14B | 767.5M | 442.6M | 502.7M | 2.3M | 38.00M | 122.78M |
Other non-current assets | 151.8M | 114.3M | 108.2M | 169.9M | 154.6M | 224.2M | 224.1M | 197.1M | 154.28M | 97.81M |
Total non-current assets | 3.61B | 2.66B | 2.84B | 2.44B | 2.04B | 1.63B | 1.43B | 900.8M | 909.11M | 910.21M |
Total assets | 7.16B | 6.04B | 5.16B | 4.61B | 3.91B | 3.40B | 2.87B | 2.32B | 2.18B | 1.88B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 0 | 0 | 0 | 163.5M | 0 | 0 | 0 | 370.47M | 360.48M |
Short term debt | 400M | 0 | 0 | 0 | 250M | 0 | 0 | 0 | 5.38M | 126.41M |
Total current liabilities | 804.4M | 343.2M | 305.4M | 323.3M | 463M | 276.6M | 444.7M | 332.5M | 440.82M | 504.31M |
| Non-current liabilities: | ||||||||||
Long term debt | 300M | 800M | 800M | 800M | 600M | 250M | 250M | 0 | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 77.8M | 104.6M | 104.8M | 96.5M | 70M | 66.6M | 63.7M | 99.2M | 143.97M | 114.52M |
Total non-current liabilities | 377.8M | 904.6M | 904.8M | 896.5M | 670M | 316.6M | 313.7M | 130.9M | 143.97M | 114.52M |
Total liabilities | 1.18B | 1.24B | 1.21B | 1.21B | 1.13B | 612.4M | 777.6M | 463.4M | 584.79M | 618.83M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |